Concepedia

Annaig Le-Halpere

AL

3

Publications

308

Citations

3

H-Index

2017

Active since

Affiliations

Sanofi (China)(Current)

University Hospital of Basel

McGill University

Sanofi (France)

Boston Children's Hospital

Annaig Le-Halpere is an author at Sanofi (China) specializing in medicine, translational research, and neuroimmunology.

ORCID

Top concepts

Publications per year

2017–2024

3

Publications

3

Intravitreous injection of AAV2-sFLT01 in patients with advanced neovascular age-related macular degeneration: a phase 1, open-label trial

Jeffrey S. Heier, Saleema Kherani, Shilpa J. Desai et al. · The Lancet · 2017 · 220 citations

, , +8

Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

Tanuja Chitnis, Brenda Banwell, Ludwig Kappos et al. · The Lancet Neurology · 2021 · 78 citations

, , +8

Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS

Tanuja Chitnis, Brenda Banwell, Ludwig Kappos et al. · Multiple Sclerosis Journal · 2024 · 10 citations · Full text

Rows per page

1–3 of 3